Imagion Biosystems is pleased to present the Company’s annual report for the year ending 31 December 2017.
Read the 2017 Annual Report to Shareholders.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal